Induce (Intellin Diabetic Foot) Feasibility Study

Launched by NATALIE GARRATT · Jul 17, 2018

Keywords

ClinConnect Summary

The rationale behind this study is if the investigators can introduce a new technology (a smart phone app) which is acceptable to patients, engages them and prompts people to take preventative health behaviours then the investigators may be able to influence the low rates of appropriate self-referral. There is evidence that links poor glycaemic control and hypertension to DFUs, so engagement in these areas of wider diabetes management needs to be reviewed, the latest National Diabetes Audit (NDA) shows only 20% of people with Type 1 and 42% of people with Type 2 diabetes achieve the 3 NICE ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * • 18 years of age will be screened to meet the eligibility criteria:
• • Consultant or GP diagnosis of diabetes mellitus (Type I or II) , documented on the electronic patient record with HbA1C greater than 48mmol/mol
• • History of a recent diabetes foot ulcer defined as being eligible for the national diabetes foot audit and classified as healed for at least 4 weeks and no more than 12 weeks
• • Able to provide informed consent
• • Has no reasons that they could not be part of the study for 12 months such as moving out the area for attending appointments or short life expectancy from a diagnosed illness
• • Owns a smart phone
• Exclusion Criteria:
• • No smart phone
• • Comorbidity such as poor eyesight which limits the use of smart phone
• • Participation in an interventional study within the last 30 days
• • Critical illness that prevents participating for a period of time